Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.

ABSTRACT:

SUBMITTER: Hemmingsen B 

PROVIDER: S-EPMC6481586 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature